Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Am Geriatr Soc. 2016 Jul;64(7):1439–1447. doi: 10.1111/jgs.14228

Table 2.

Model coefficients and risk scores

Clinical model EMR model
Covariates Hazard ratio*
(95% CI)
Points Hazard ratio*
(95% CI)
Points
Age
  65–69 REF 0 REF 0
  70–74 0.87 (0.53, 1.42) 0.91 (0.56, 1.49)
  75–79 1.09 (0.69, 1.72) 1.18 (0.74, 1.86) 1
  80–84 1.16 (0.73, 1.87) 1 1.31 (0.82, 2.11)
  85–89 1.78 (1.11, 2.87) 2 2.19 (1.35, 3.54) 3
  90+ 1.77 (1.01, 3.10) 2.43 (1.40, 4.20)
Gender
  Male 1.75 (1.40, 2.19) 2 1.73 (1.38, 2.17) 2
Comorbidity
  COPD 1.59 (1.23, 2.06) 2 2.03 (1.57, 2.62) 3
  CHF 1.61 (1.17, 2.19) 2 1.91 (1.40, 2.60) 2
  Pneumonia 1.94 (1.56, 2.41) 2 NI NI
  Home oxygen use in prior 24
months
1.68 (1.02, 2.76) 2 NI NI
Functional
  Any difficulty dressing yourself 1.42 (1.04, 1.93) 1 NA NA
  Difficulty walking a half- mile
    Some difficulty 1.33 (0.98, 1.80) 1 NA NA
    Much difficulty/cannot do 1.44 (1.08, 1.91) NA NA
Behavioral
  History of alcohol- related
aggressive behavior
1.69 (1.12, 2.54) 2 NA NA
  Body mass index
    <18.5 1.39 (0.76, 2.54) 1 1.41 (0.77, 2.60) 1
    18.5 to <25 REF 0 REF 0
    25 to <30 0.75 (0.58, 0.95) −1 0.77 (0.60, 0.98) −1
    30 to <35 0.69 (0.49, 0.97) 0.78 (0.56, 1.09)
    ≥35 0.45 (0.25, 0.81) −3 0.54 (0.30, 0.96) −2
Pharmacy
  Inhaled corticosteroid 1.49 (1.05, 2.12) 1 1.75 (1.21, 2.51) 2
  Oral corticosteroid 1.87 (1.32, 2.66) 2 2.22 (1.56, 3.15) 3
C-index (95% CI) Development
cohort
0.72 (0.70, 0.75) 0.72 (0.69,
0.75)
0.69 (0.67, 0.72) 0.69 (0.66,
0.72)
C-index (95% CI) Validation
cohort
0.70 (0.66, 0.73) 0.69 (0.66,
0.73)
0.69 (0.66, 0.73) 0.69 (0.66,
0.73)
*

Estimate from the Fine and Gray model, also known as a proportional sub-distribution hazards model (see Supplemental Methods)

NI = Not included in final model

NA = Not applicable (i.e. variable not expected to be available in EMR)